KNect365 Life Sciences is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Clinical Trials Innovation

Clinical Trials State of the Industry Report 2019

ArticleImage

Download the exclusive report

Clinical trials are at an interesting point in 2019. Technology such as wearables and AI offers huge potential if the many challenges can be overcome, whilst the promise of virtual trials provides its own set of operational obstacles. Increasingly complex partnerships and outsourcing strategies mean vendor oversight is more important than ever and of course patient recruitment and engagement will always remain central to every study.

In May 2019 we surveyed clinical trials professionals from pharma, CROs, sites, service providers, consultancies, academia and patient groups around the world. This final report based on 214 responses reveals unique insights into the state of the industry today – the toughest challenges and biggest areas for potential.

To download the exclusive whitepaper simply log in or register for a KNect365 account, which will give you access to all our exclusive premium content.

Have any questions about the report or interested in sponsoring a future whitepaper? Email andrew.burrows@knect365.com.

Create your KNect365 account

Access this and more industry news, views, and keynotes from influencers and market movers.
You may be interested in attending our "Clinical Trials Europe" event.
Please select if you'd like more information on:

Tell us more about yourself

This will help ensure you see articles, market intelligence and event updates relevant to you.

What best characterises the part of the company you work for?

Show
Please tick these boxes if you do not wish to receive marketing information relevant to you from KNect365 Life Sciences:
By creating an account you agree to Informa's Terms of Use and Privacy Policy